Tema ETFs LLC lessened its stake in shares of CME Group Inc. (NASDAQ:CME – Free Report) by 37.8% during the second quarter, Holdings Channel reports. The fund owned 6,017 shares of the financial services provider’s stock after selling 3,651 shares during the quarter. Tema ETFs LLC’s holdings in CME Group were worth $1,329,000 as of its most recent SEC filing.
Several other institutional investors and hedge funds have also bought and sold shares of CME. Vanguard Group Inc. increased its stake in CME Group by 1.7% in the fourth quarter. Vanguard Group Inc. now owns 35,895,583 shares of the financial services provider’s stock valued at $9,802,366,000 after purchasing an additional 588,509 shares in the last quarter. State Street Corp raised its holdings in shares of CME Group by 0.4% during the fourth quarter. State Street Corp now owns 16,144,525 shares of the financial services provider’s stock valued at $4,408,747,000 after purchasing an additional 56,725 shares during the period. Norges Bank bought a new position in shares of CME Group during the 4th quarter worth about $1,523,241,000. Bank of New York Mellon Corp boosted its position in shares of CME Group by 2.8% during the 4th quarter. Bank of New York Mellon Corp now owns 4,924,475 shares of the financial services provider’s stock worth $1,344,776,000 after purchasing an additional 134,242 shares in the last quarter. Finally, Raymond James Financial Inc. grew its stake in shares of CME Group by 5.4% in the 4th quarter. Raymond James Financial Inc. now owns 4,319,763 shares of the financial services provider’s stock valued at $1,179,858,000 after buying an additional 222,890 shares during the period. 87.75% of the stock is owned by institutional investors.
Key Headlines Impacting CME Group
Here are the key news stories impacting CME Group this week:
- Positive Sentiment: CME Group averaged a record 27 million contracts traded per day in July. Ongoing uncertainty over inflation, interest rates and geopolitical risks is encouraging hedging and speculative activity across CME’s markets, potentially supporting transaction revenue. CME Group Averaged a Record 27 Million Contracts a Day in July
- Positive Sentiment: The exchange plans to expand 24/7 trading to its 100-ounce silver futures contract, subject to regulatory approval. The move follows strong weekend activity in one-ounce gold futures and could increase participation, liquidity and CME’s reach in precious-metals markets. CME Expands Silver Trading to 24/7
- Positive Sentiment: A Seeking Alpha analysis argues that CME is essential market infrastructure and assigns a “Buy” view, while recent trading volume and the company’s earnings beat reinforce the investment case. CME Group: Buy the Market’s Infrastructure
- Neutral Sentiment: July inflation and wholesale-price data came in softer than expected, causing traders to reassess the likelihood and timing of Federal Reserve rate moves. Easier-policy expectations can support markets, but reduced rate uncertainty could eventually lessen volatility-driven volume. Top Markets Commentator: July Inflation Was Definitely Better Than Expected
- Neutral Sentiment: Planned futures on Nvidia H100 and B200 computing capacity could open a new growth market, although Nvidia’s dominance may limit liquidity and prevent the contracts from becoming a broadly traded commodity. Why Nvidia May Stand in the Way of Wall Street’s Plans to Turn AI Compute Into a Commodity
- Negative Sentiment: Brokerage coverage remains cautious, with CME receiving a consensus “Hold” rating despite some analysts’ optimism. This may limit upside unless trading growth and new products translate into stronger earnings. CME Group Receives Consensus Rating of Hold
CME Group Price Performance
CME Group (NASDAQ:CME – Get Free Report) last announced its earnings results on Wednesday, July 22nd. The financial services provider reported $2.99 EPS for the quarter, beating the consensus estimate of $2.91 by $0.08. CME Group had a net margin of 63.30% and a return on equity of 15.60%. The company had revenue of $1.71 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same quarter in the prior year, the company posted $2.96 earnings per share. The firm’s revenue for the quarter was up .8% on a year-over-year basis. As a group, analysts anticipate that CME Group Inc. will post 12.27 earnings per share for the current fiscal year.
CME Group Dividend Announcement
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 25th. Shareholders of record on Wednesday, September 9th will be given a $1.30 dividend. This represents a $5.20 dividend on an annualized basis and a yield of 1.9%. The ex-dividend date of this dividend is Wednesday, September 9th. CME Group’s dividend payout ratio is presently 44.11%.
Insider Activity
In other CME Group news, insider Hilda Harris Piell sold 5,753 shares of the stock in a transaction dated Monday, May 18th. The shares were sold at an average price of $304.63, for a total value of $1,752,536.39. Following the completion of the sale, the insider owned 27,702 shares in the company, valued at approximately $8,438,860.26. This trade represents a 17.20% decrease in their position. The transaction was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, Director William R. Shepard bought 325 shares of the company’s stock in a transaction on Thursday, June 25th. The shares were purchased at an average cost of $230.57 per share, for a total transaction of $74,935.25. Following the transaction, the director owned 260,442 shares in the company, valued at approximately $60,050,111.94. This represents a 0.12% increase in their ownership of the stock. Additional details regarding this purchase are available in the official SEC disclosure. Company insiders own 0.30% of the company’s stock.
Analyst Upgrades and Downgrades
A number of analysts recently commented on CME shares. Wall Street Zen lowered CME Group from a “sell” rating to a “strong sell” rating in a research report on Saturday, August 1st. UBS Group cut their price target on CME Group from $310.00 to $260.00 and set a “buy” rating on the stock in a report on Monday, July 6th. JPMorgan Chase & Co. raised their price objective on CME Group from $249.00 to $250.00 and gave the company an “underweight” rating in a research note on Thursday, July 23rd. Rothschild & Co Redburn upgraded CME Group from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $316.00 to $323.00 in a report on Thursday, June 11th. Finally, Erste Group Bank lowered CME Group from a “buy” rating to a “hold” rating in a research report on Friday, June 5th. Ten investment analysts have rated the stock with a Buy rating, five have given a Hold rating and three have issued a Sell rating to the company’s stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $291.81.
Check Out Our Latest Stock Analysis on CME Group
CME Group Company Profile
CME Group Inc is a global markets company that operates some of the world’s largest and most liquid derivatives exchanges, including the Chicago Mercantile Exchange (CME), the Chicago Board of Trade (CBOT), the New York Mercantile Exchange (NYMEX) and COMEX. The firm offers futures and options contracts across a broad range of asset classes — including interest rates, equity indexes, foreign exchange, energy, agricultural commodities and metals — and serves a diverse client base of institutional investors, commercial hedgers, brokers and retail participants.
The company’s core services include electronic trading on the CME Globex platform, central clearing through CME Clearing, and distribution of market data, indexes and analytics.
Read More
- Five stocks we like better than CME Group
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Want to see what other hedge funds are holding CME? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for CME Group Inc. (NASDAQ:CME – Free Report).
Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.
